Be Ready to Discuss Tirzepatide for Sleep Apnea
April 2025
Tirzepatide (Zepbound) will be the first Rx med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults.
It’s only for patients with obesity who are working on lifestyle changes (healthy eating, increasing physical activity, etc).
Using tirzepatide 10 mg or 15 mg weekly for 1 year reduces breathing interruptions by about 20 episodes/hour more than placebo...in patients with or without concomitant continuous positive airway pressure (CPAP).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote